CVS HEALTH Corp
CVSAPI behind this page
CVS Q3 2025 request
Playground key active
/api/financials?ticker=CVS&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 64,590 | 59,674 | +8.2% |
| Service | 3,930 | 4,279 | -8.2% |
| Premiums Earned Net | 33,719 | 30,925 | +9.0% |
| Net Investment Income | 632 | 550 | +14.9% |
Show Business Segments breakouts |
|||
| Corporate/ Other | 120 | 128 | -6.2% |
| Corporate/ Other · Corporate/ Other | 120 | 128 | -6.2% |
| Health Care Benefits | 513 | 423 | +21.3% |
| Health Care Benefits · Operating Segments | 513 | 423 | +21.3% |
| Health Services | -1 | -1 | 0.0% |
| Health Services · Operating Segments | -1 | -1 | 0.0% |
| Revenue | 102,871 | 95,428 | +7.8% |
Show Business Segments breakouts |
|||
| Corporate/ Other · Corporate/ Other | 133 | 142 | -6.3% |
| Health Care Benefits · Intersegment Elimination | -49 | -18 | -172.2% |
| Health Care Benefits · Operating Segments | 35,993 | 32,996 | +9.1% |
| Health Services · Intersegment Elimination | -6,913 | -3,336 | -107.2% |
| Health Services · Operating Segments | 2,467 | 2,780 | -11.3% |
| Health Services · Operating Segments | 20,392 | 17,214 | +18.5% |
| Health Services · Operating Segments | 26,408 | 24,136 | +9.4% |
| Health Services · Operating Segments | 49,266 | 44,129 | +11.6% |
| Pharmacy & Consumer Wellness · Intersegment Elimination | -11,773 | -10,908 | -7.9% |
| Pharmacy & Consumer Wellness · Operating Segments | 36,214 | 32,423 | +11.7% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -18,735 | -14,262 | -31.4% |
| Operating Segments and Corporate/ Other | 121,606 | 109,690 | +10.9% |
| Cost of Revenue | 57,045 | 52,948 | +7.7% |
Show Business Segments breakouts |
|||
| Health Services · Operating Segments | 45,230 | 40,381 | +12.0% |
| Pharmacy & Consumer Wellness · Operating Segments | 29,647 | 26,032 | +13.9% |
| Policyholder Benefits And Claims Incurred Net | 32,020 | 29,922 | +7.0% |
Show Business Segments breakouts |
|||
| Corporate/ Other · Corporate/ Other | 47 | 49 | -4.1% |
| Health Care Benefits · Operating Segments | 31,319 | 29,443 | +6.4% |
| Health Services · Operating Segments | 1,291 | 936 | +37.9% |
| Other Cost And Expense Operating | 11,288 | 10,557 | +6.9% |
| Goodwill Impairment Loss | 5,725 | — | — |
Show Reporting Unit breakouts |
|||
| Health Care Delivery Reporting Unit | 5.7 | — | — |
| Total Costs & Expenses | 106,078 | 94,596 | +12.1% |
| Operating Income | -3,207 | 832 | -485.5% |
| Deconsolidation Gain Or Loss Amount | 483 | — | — |
| Interest Expense | -784 | -752 | -4.3% |
| Other Non-Operating Income (Expense) | 26 | 25 | +4.0% |
| Income Before Taxes | -3,482 | 105 | -3416.2% |
| Income Tax Expense (Benefit) | 508 | 34 | +1394.1% |
| Net Income | -3,990 | 71 | -5719.7% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | -15 | -16 | +6.2% |
| Parent | -3,975 | 87 | -4669.0% |
| Retained Earnings | -3,975 | 87 | -4669.0% |
| Net Income Loss Attributable To Noncontrolling Interest | 15 | 16 | -6.2% |
| Net Income | -3,975 | 87 | -4669.0% |
| EPS (Basic) | -3.13 | 0.07 | -4571.4% |
| EPS (Diluted) | -3.13 | 0.07 | -4571.4% |
| Wtd Avg Shares (Basic) | 1,269 | 1,259 | +0.8% |
| Wtd Avg Shares (Diluted) | 1,269 | 1,259 | +0.8% |
| Comprehensive Income | -3,831 | 615 | -722.9% |
| Net Income Loss Available To Common Stockholders Basic | -3,975 | 87 | -4669.0% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 9,098 | 6,875 | +32.3% |
| Short-Term Investments | 2,134 | 2,805 | -23.9% |
Show Total Investments [Axis] breakouts |
|||
| Debt securities available for sale | 1,978 | 2,633 | -24.9% |
| Mortgage loans | 156 | 172 | -9.3% |
| Accounts Receivable | 43,857 | 36,179 | +21.2% |
| Inventory | 18,962 | 17,649 | +7.4% |
| Other Assets Current | 3,058 | 3,835 | -20.3% |
| Total Current Assets | 77,109 | 67,343 | +14.5% |
| Non-Current Assets | |||
| Long Term Investments | 31,553 | 28,939 | +9.0% |
Show Total Investments [Axis] breakouts |
|||
| Debt securities available for sale | 25,857 | 23,857 | +8.4% |
| Mortgage loans | 1,367 | 1,315 | +4.0% |
| Other Investments | 4,329 | 3,767 | +14.9% |
| Operating Lease Right-of-Use Assets | 15,271 | 16,231 | -5.9% |
| Goodwill | 85,478 | — | — |
Show Business Segments breakouts |
|||
| Health Care Benefits | 46,644 | — | — |
| Health Services | 28,272 | — | — |
| Pharmacy & Consumer Wellness | 10,562 | — | — |
Show Reporting Unit breakouts |
|||
| Health Care Delivery Reporting Unit | 4.2 | — | — |
| Other Non-Current Assets | 5,160 | 4,763 | +8.3% |
| Total Assets | 255,327 | 252,427 | +1.1% |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 12,838 | 12,728 | +0.9% |
| Intangible Assets Net Excluding Goodwill | 25,984 | 27,817 | -6.6% |
| Separate Account Assets | 1,934 | 3,334 | -42.0% |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Fair Value Measurements Recurring | 36 | 203 | -82.3% |
| Fair Value Inputs Level1 · Fair Value Measurements Recurring | 5 | 1 | +400.0% |
| Fair Value Inputs Level1 · Fair Value Measurements Recurring | 31 | 202 | -84.7% |
| Fair Value Inputs Level2 · Fair Value Measurements Recurring | 1,854 | 3,233 | -42.7% |
| Fair Value Inputs Level2 · Fair Value Measurements Recurring | 1,337 | 2,372 | -43.6% |
| Fair Value Inputs Level2 · Fair Value Measurements Recurring | 155 | 164 | -5.5% |
| Fair Value Inputs Level2 · Fair Value Measurements Recurring | 362 | 697 | -48.1% |
| Fair Value Inputs Level3 · Fair Value Measurements Recurring | 1 | — | — |
| Fair Value Inputs Level3 · Fair Value Measurements Recurring | 1 | — | — |
Show Financial Instrument breakouts |
|||
| Commercial Mortgage Backed Securities · Fair Value Measurements Recurring | 3 | 3 | 0.0% |
| Domestic Corporate Debt Securities · Fair Value Measurements Recurring | 290 | 527 | -45.0% |
| Foreign Corporate Debt Securities · Fair Value Measurements Recurring | 42 | 52 | -19.2% |
| Residential Mortgage Backed Securities · Fair Value Measurements Recurring | 7 | 68 | -89.7% |
| US Government Agencies Debt Securities · Fair Value Measurements Recurring | 36 | 223 | -83.9% |
| US States And Political Subdivisions · Fair Value Measurements Recurring | 11 | 16 | -31.2% |
Show Balance Sheet Location breakouts |
|||
| Other Receivables · Fair Value Measurements Recurring | 43 | — | — |
Show Fair Value By Measurement Frequency breakouts |
|||
| Fair Value Measurements Recurring | 1,891 | 3,436 | -45.0% |
| Fair Value Measurements Recurring · Cash And Cash Equivalents | 160 | 165 | -3.0% |
| Fair Value Measurements Recurring · Common/collective trusts | 1,337 | 2,372 | -43.6% |
| Fair Value Measurements Recurring · Debt Securities | 394 | 899 | -56.2% |
| Fair Value Measurements Recurring · Other asset-backed securities | 5 | 10 | -50.0% |
| Fair Value Measurements Recurring · Separate Account Cash And Cash Equivalents | 160 | 165 | -3.0% |
| Fair Value Measurements Recurring · Separate Account Debt Security | 394 | 899 | -56.2% |
| Current Liabilities | |||
| Accounts Payable Trade Current | 17,764 | 15,713 | +13.1% |
| Pharmacy Claims And Discounts Payable Current | 27,085 | 23,917 | +13.2% |
| Accrued Liabilities | 23,415 | 20,174 | +16.1% |
| Other Insurance Liabilities Current | 1,096 | 1,051 | +4.3% |
| Operating Lease Liability Current | 1,909 | 1,912 | -0.2% |
| Long Term Debt And Capital Lease Obligations Current | 4,081 | 4,910 | -16.9% |
| Total Current Liabilities | 92,695 | 84,627 | +9.5% |
| Deferred Revenue (Current) | 58 | 174 | -66.7% |
| Commercial Paper | 1,247 | 800 | +55.9% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 14,007 | 15,258 | -8.2% |
| Deferred Tax Liabilities | 3,547 | 3,632 | -2.3% |
| Other Insurance Liabilities Noncurrent | 4,767 | 5,162 | -7.7% |
| Other Non-Current Liabilities | 4,759 | 5,484 | -13.2% |
| Total Liabilities | 182,217 | 177,321 | +2.8% |
| Other Liabilities | |||
| Liability For Claims And Claims Adjustment Expense And Health Care Organization Accounts Payable To Third Party Payor | 16,098 | 15,237 | +5.7% |
| Short Term Borrowings | 1,247 | 800 | +55.9% |
Show Short Term Debt Type breakouts |
|||
| Commercial Paper | 1.2 | 800 | -99.8% |
| Long Term Debt And Capital Lease Obligations | 60,508 | 59,824 | +1.1% |
| Separate Accounts Liability | 1,934 | 3,334 | -42.0% |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 50,181 | 49,510 | +1.4% |
| Treasury Stock Common Value | -36,776 | -36,813 | +0.1% |
| Retained Earnings | 59,107 | 62,038 | -4.7% |
| Accumulated Other Comprehensive Income | 416 | 209 | +99.0% |
| Total Stockholders' Equity | 72,928 | 74,944 | -2.7% |
| Minority Interest | 182 | 162 | +12.3% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 73,110 | 75,106 | -2.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Net Gain Loss Including Portion Attributable To Noncontrolling Interest | -211 | -264 | +20.1% |
| Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest | 6 | — | — |
| Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest | 220 | 232 | -5.2% |
| Accumulated Net Investment Gain Loss Including Portion Attributable To Noncontrolling Interest | 196 | 115 | +70.4% |
| Accumulated Other Comprehensive Income | 416 | 209 | +99.0% |
| Aoci Including Portion Attributable To Noncontrolling Interest | 416 | 209 | +99.0% |
| Change in discount rate on long-duration insurance reserves: | 205 | 126 | +62.7% |
| Common Stock Including Additional Paid In Capital | 50,181 | 49,510 | +1.4% |
| Noncontrolling Interest | 182 | 162 | +12.3% |
| Parent | 72,928 | 74,944 | -2.7% |
| Retained Earnings | 59,107 | 62,038 | -4.7% |
| Treasury Stock Common | -36,776 | -36,813 | +0.1% |
| Total Liabilities & Equity | 255,327 | 252,427 | +1.1% |
| Common Stock | 18 | 18 | 0.0% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Proceeds From Customers | 283,378 | 264,538 | +7.1% |
| Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies | -157,849 | -145,469 | -8.5% |
| Payments For Insurance Benefits | -88,769 | -80,357 | -10.5% |
| Payments To Suppliers And Employees | -27,308 | -28,933 | +5.6% |
| Proceeds From Interest And Dividends Received | 1,494 | 1,288 | +16.0% |
| Interest Paid | -2,529 | -2,391 | -5.8% |
| Income Taxes Paid | -1,168 | -1,429 | +18.3% |
| Net Cash from Operations | 7,249 | 7,247 | 0.0% |
| Depreciation & Amortization | 3,459 | 3,450 | +0.3% |
Show Business Segments breakouts |
|||
| Corporate/ Other | 310 | 298 | +4.0% |
| Health Care Benefits | 1,199 | 1,196 | +0.3% |
| Health Services | 781 | 792 | -1.4% |
| Pharmacy & Consumer Wellness | 1,169 | 1,164 | +0.4% |
| Stock-Based Compensation | 400 | 403 | -0.7% |
| Gain Loss On Sale Of Business | 236 | — | — |
Show Business Segments breakouts |
|||
| Health Services · Disposal Group Disposed Of By Sale Not Discontinued Operations | 236 | — | — |
| Deferred Income Taxes And Other Items | -440 | -912 | +51.8% |
| Change in Accounts Receivable | -7,537 | -986 | -664.4% |
| Change in Inventory | -982 | 355 | -376.6% |
| Increase Decrease In Other Operating Assets | -588 | -850 | +30.8% |
| Change in Accounts Payable | 5,052 | 2,169 | +132.9% |
| Increase Decrease In Insurance Liabilities | 734 | 2,878 | -74.5% |
| Increase Decrease In Other Operating Liabilities | 2,868 | -3,063 | +193.6% |
| Investing Activities | |||
| Proceeds From Sale And Maturity Of Marketable Securities | 9,640 | 7,634 | +26.3% |
| Payments To Acquire Investments | -11,045 | -12,677 | +12.9% |
| Capital Expenditures | -2,048 | -2,013 | -1.7% |
| Payments To Acquire Businesses Net Of Cash Acquired | -429 | -85 | -404.7% |
| Other Investing Activities | 9 | 75 | -88.0% |
| Net Cash from Investing | -3,873 | -7,066 | +45.2% |
| Financing Activities | |||
| Proceeds From Repayments Of Commercial Paper | -872 | 600 | -245.3% |
| Proceeds From Issuance Of Long Term Debt | 3,969 | 4,959 | -20.0% |
| Repayments Of Long Term Debt | -3,609 | -1,706 | -111.5% |
| Payments Of Dividends | -2,552 | -2,535 | -0.7% |
| Proceeds From Stock Options Exercised | 308 | 342 | -9.9% |
| Tax Withholding for Share Compensation | -145 | -181 | +19.9% |
| Proceeds From Payments For Other Financing Activities | -7 | -22 | +68.2% |
| Net Cash from Financing | -2,908 | -1,566 | -85.7% |
| Other Cash Flow | |||
| Net Change in Cash | 468 | -1,385 | +133.8% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9,352 | 7,140 | +31.0% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.